microbiome in matched mBAL and TA specimens from a prospective cohort of critically 48 ill adults. We observed moderate differences between sample types across all patients 49 (Pearson correlation of 0.72, 95% CI: 0.68 -0.76), however we found significant 50 compositional similarity in patients with bacterial pneumonia, whose microbial 51 communities were characterized by a dominant pathogen (Pearson correlation of 0.92, 52 95% CI: 0.88 -0.95). In addition, we found that both mBAL and TA were similar in 53 terms of microbial burden, abundance of oropharyngeal taxa, and microbial diversity. 54
Our findings suggest that TA sampling provides a similar assessment of airway 55 microbiota as more invasive testing by mBAL, and that this similarity is most significant 56 in the setting of bacterial pneumonia. 57 58 59 60
Importance ( 150 / 150 words ): 61
Less invasive tracheal aspirate (TA) sampling has historically been considered 62 inferior to mini-bronchial alveolar lavage for both diagnostic microbiology and for 63 investigations of the lung microbiome. Recent studies demonstrating that sample type 64 does not affect patient outcomes has led to shift in clinical practice guidelines, which 65 now recommend TA. Despite the implications of this shift for both patient care and lung 66 microbiome research, differences in microbial composition between fluid types had not 67 been assessed using metagenomic methods. To address this gap, we employed 68 metagenomic sequencing to characterize the microbial composition of matched mBAL 69 and TA specimens. While modest differences in taxonomic composition were observed, 70 mBAL and TA were highly similar with respect to microbial burden and diversity, and in 71 patients with bacterial pneumonia. Our findings provide metagenomic evidence that TA 72 is an acceptable replacement for more invasive mBAL sampling, which has implications 73 both for clinical microbiology and lung microbiome research. Pneumonia causes more deaths each year in the United States than any other 78 type of infectious disease (1). The ability to accurately detect etiologic pathogens and 79 distinguish them from background commensal microbiota is essential for guiding optimal 80 antimicrobial treatment. In patients requiring mechanical ventilation, less invasive 81 tracheal aspirate (TA) sampling has historically been considered inferior to specimen 82 collection by mini-bronchoalveolar lavage/telescoping catheter (mBAL) due to the 83 potential for oropharyngeal microbiota contamination (2, 3). This idea has been 84 challenged, however, by studies demonstrating a lack of clinically significant differences 85 between sample types, (2-5) and a greater acceptance of TA sampling is now 86 reflected in recent updates to clinical practice guidelines (6). Despite the broad potential 87 implications of this shift in diagnostic sampling approach, relatively little information 88 exists regarding microbial composition differences between mBAL and TA specimens 89 and the potential implications of such differences for both clinical diagnostic testing and 90 airway microbiome studies. 91
To address this gap in knowledge, we used shotgun metagenomic next 92 generation sequencing (mNGS) to evaluate the microbial compositions of matched 93 mBAL and TA specimens from 52 adults who were admitted to the intensive care unit 94 with acute respiratory failure and enrolled under University of California San Francisco 95 protocol 10-02701 as detailed in (Table S1) (Table S2) . Patients with PCR-confirmed viral etiologies were also 104 included in the PNA-ind group because occult bacterial co-infection could not be 105
excluded. 106
Excess mBAL and TA specimens collected on the same day, within 72 hours of 107 intubation, underwent DNA extraction and sequencing library preparation according to 108 previously described methods (8). Following paired-end Illumina sequencing, we 109 employed a custom bioinformatics pipeline (8) to detect and profile airway microbes 110 ( Figure S1) . We sequenced no-template water control samples and restricted analyses 111 to taxa present at > 1% of the microbial population by abundance, as previously 112 described (2, 9) . No microbe was universally present in every sample, suggesting that 113 systematic contamination across TA or mBAL sampling methods was unlikely. 114
We began by evaluating the correlation between genus abundance in mBAL and 115 TA specimens and identified a Pearson correlation of 0.72 (95% CI: 0.68 -0.76), 116 suggesting moderate differences (Figure 1A) . Next, we examined microbial burden 117 (total genus alignments per million reads sequenced) and found no significant 118 differences between TA and mBAL specimens (Median = 43.30 (IQR: 6.69 -327.93) 119 versus 26.89 (5.66 -167.63), p = 0.66 by Wilcoxon rank sum). Oropharyngeal 120 microbiota have historically been suspected to compromise TA specimens, and thus we 121 next evaluated for differences in the abundance of common oropharyngeal microbiota Page 7 of 11 (2) . Surprisingly, we found no statistically significant differences between mBAL and TA 123 specimens with respect to Prevotella, Veillonella, Streptococcus, Fusobacterium, 124 Rothia, or Neisseria abundance (Table 1B) . We also identified no significant inter-125 specimen type differences in microbial -diversity based on Bray-Curtis dissimilarity 126 index (p = .31 by PERMANOVA). 127
We reasoned that differences in microbial composition between mBAL and TA 128 specimens would be most clinically significant if they impacted diagnostic accuracy in 129 patients with pneumonia, and thus assessed taxonomic similarity between the PNA-pos 130 and PNA-neg groups. We found significantly greater similarity in PNA-pos subjects as 131 compared to the PNA-neg subjects (Pearson correlation of 0.92 (0.88 -0.95) versus 132 0.39 (0.28 -0.49), p < 1.00 x 10 -3 ), suggesting that pathogen dominance of the lung 133 microbiome during infection may drive compositional similarity (9, 10) (Table 1A, Figure  134 1B). For both sample types, a culture-confirmed pathogen was the most abundant 135 microbe detected by mNGS in 14 (93%) of PNA-pos subjects, and the second most 136 abundant in the remaining subject ( Table S3 ). mNGS of mBAL specimens detected all 137 23 culture-identified microbes, while mNGS of TA samples identified 22. The discrepant 138 microbe was from a polymicrobial culture and was detected by mNGS in the TA 139 specimen, but present at < 1% relative abundance and therefore indistinguishable from 140 background using our bioinformatic approach (Table S3) . 141
Reduced alpha diversity of the human respiratory microbiome has been 142 described as an ecological marker of infection(9, 10), and thus we next asked whether 143
Shannon's Diversity Index (SDI) differed by specimen type. We found that SDI differed 144 significantly between PNA-pos and PNA-neg patients within mBAL samples, and a versus TA specimens (r = 0.72 overall, (95% CI: 0.68 -0.76)). B. Pearson correlation 204 was stronger among microbes from PNA-pos subjects (red plus, r = 0.92 (95% CI: 0.88 205 -0.95)) than PNA-neg subjects (blue plus, r = 0.39 (95% CI: 0.28 -0.49)). 206 207 .00 (4.00-9.00) p = 6.5 x 10 -2 8.00 (4.00-13.50) p = 1.2 x 10 -3 p = 5.0 x 10 -2 Shannon Diversity 1.05 (0.71-1.55) p = 4.7 x 10 -2 1.45 (0.74-2.05) p = 5.2 x 10 -6 p = 6.0 x 10 -2 B. mBAL TA Genus mean rpM (IQR) mean rpM (IQR) mBAL vs. TA Prevotella 0.07 (0.00 -0.06) 0.02 (0.00 -0.03) p = 0.15 Veillonella 0.03 (0.00 -0.02) 0.03 (0.00 -0.02) p = 0.99 Streptococcus 0.20 (0.00 -0.33) 0.18 (0.00 -0.34) p = 0.88 Fusobacterium 0.02 (0.00 -0.00) 0.01 (0.00 -0.00) p = 0.53 Rothia 0.03 (0.00 -0.03) 0.01 (0.00 -0.00) p = 0.31 Neisseria 0.04 (0.00 -0.02) 0.03 (0.00 -0.02) p = 0.72 
mini-BAL

